Atom Investors LP Biogen Inc. Transaction History

Atom Investors LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $520,466 - $655,760	-2,686 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $601,449 - $772,950	2,686 New	2,686 $644,000
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $10.3 Million - $12.1 Million	-42,471 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $5.54 Million - $8.33 Million	23,437 Added 123.13%	42,471 $10.4 Million
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $1.9 Million - $2.19 Million	7,158 Added 60.27%	19,034 $5.4 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $5.4 Million - $7.15 Million	-20,871 Reduced 63.73%	11,876 $3.18 Million
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $903,336 - $1.15 Million	3,360 Added 11.43%	32,747 $10.4 Million
Q4 2019 Feb 13, 2020	SELL	$220.06 - $304.07 $4 Million - $5.53 Million	-18,176 Reduced 38.21%	29,387 $8.72 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $5.32 Million - $5.96 Million	24,444 Added 105.73%	47,563 $11.1 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $4.42 Million - $4.87 Million	20,162 Added 681.84%	23,119 $5.41 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $640,811 - $1 Million	2,957 New	2,957 $699,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.